Prospects for Inhibitors of Protein Tyrosine Phosphatase 1B as Antidiabetic Drugs
- 20 July 2004
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (17) , 4142-4146
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mechanism of action of pyridazine analogues on protein tyrosine phosphatase 1B (PTP1B)Bioorganic & Medicinal Chemistry Letters, 2004
- PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic miceProceedings of the National Academy of Sciences, 2002
- A Variation in 3′ UTR of hPTP1B Increases Specific Gene Expression and Associates with Insulin ResistanceThe American Journal of Human Genetics, 2002
- Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase DomainsMolecular and Cellular Biology, 2001
- Effect of vanadium on insulin sensitivity and appetiteMetabolism, 2001
- Pulling Strings Below the Surface: Hormone Receptor Signaling Through Inhibition of Protein Tyrosine PhosphatasesEndocrine, 2001
- Identification of Tyrosine Phosphatases That Dephosphorylate the Insulin ReceptorJournal of Biological Chemistry, 2000
- Increased Insulin Sensitivity and Obesity Resistance in Mice Lacking the Protein Tyrosine Phosphatase-1B GeneScience, 1999
- Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q.Journal of Clinical Investigation, 1997
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997